Early-onset epilepsy and inborn errors of metabolism: A large retrospective pediatric cohort.

BACKGROUND: Inborn errors of metabolism (IEM) are an under-recognised cause of childhood epilepsy. Early diagnosis is critical because specific treatments can substantially alter the disease course. METHODS: We performed a retrospective study on 21,072 children evaluated for epilepsy in two Child Neurology referral centres in Eastern Sicily (i.e. Messina, Catania, and Enna) between January 2001 and December 2025. Medical records were reviewed to identify patients with a confirmed IEM diagnosis. Clinical, electrophysiological, neuroimaging, and treatment data were collected and analysed. RESULTS: Fifty-seven children (0.27%) had a co-diagnosis of epilepsy and IEM (28 males, 29 females). Lysosomal storage disorders were the most common category (31.6%), followed by aminoacidopathies (22.8%), mitochondrial disorders (15.8%), congenital disorders of glycosylation (CDG, 12.3%), and organic acidaemias (7.0%). Seizure onset occurred before the age of three years in 83.3% of IEM cases, compared with 27.6% of children with non-metabolic epilepsy (OR 12.3; 95% CI 6.2-24.4; p < 0.001). Diagnostic delay exceeded 3.5 years from first seizure in half the cohort. Approximately 50% of patients showed drug-resistant epilepsy despite multi-drug anti-seizure medication therapy. CONCLUSIONS: IEM should be systematically considered in any child presenting with epilepsy, particularly when onset occurs in the first three years of life. A structured stepwise diagnostic approach can substantially reduce diagnostic delay and facilitate access to disease-specific therapies.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2026-11-12
DOI
https://doi.org/10.1016/j.yebeh.2026.111368
Primary Topic
Metabolism and Genetic Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Early-onset epilepsy and inborn errors of metabolism: A large retrospective pediatric cohort.

Agata Fiumara, Maria C. Costanzo, Concetta Meli, Martino Ruggieri et al.
PubMed
Metabolism and Genetic Disorders
article

Early-onset epilepsy and inborn errors of metabolism: A large retrospective pediatric cohort.

Agata Fiumara, Maria C. Costanzo, Concetta Meli, Martino Ruggieri, Maria Elena Cucuzza, Filippo Greco, Maria Chiara Spano, Andrea D Praticò
article en

Abstract

BACKGROUND: Inborn errors of metabolism (IEM) are an under-recognised cause of childhood epilepsy. Early diagnosis is critical because specific treatments can substantially alter the disease course. METHODS: We performed a retrospective study on 21,072 children evaluated for epilepsy in two Child Neurology referral centres in Eastern Sicily (i.e. Messina, Catania, and Enna) between January 2001 and December 2025. Medical records were reviewed to identify patients with a confirmed IEM diagnosis. Clinical, electrophysiological, neuroimaging, and treatment data were collected and analysed. RESULTS: Fifty-seven children (0.27%) had a co-diagnosis of epilepsy and IEM (28 males, 29 females). Lysosomal storage disorders were the most common category (31.6%), followed by aminoacidopathies (22.8%), mitochondrial disorders (15.8%), congenital disorders of glycosylation (CDG, 12.3%), and organic acidaemias (7.0%). Seizure onset occurred before the age of three years in 83.3% of IEM cases, compared with 27.6% of children with non-metabolic epilepsy (OR 12.3; 95% CI 6.2-24.4; p < 0.001). Diagnostic delay exceeded 3.5 years from first seizure in half the cohort. Approximately 50% of patients showed drug-resistant epilepsy despite multi-drug anti-seizure medication therapy. CONCLUSIONS: IEM should be systematically considered in any child presenting with epilepsy, particularly when onset occurs in the first three years of life. A structured stepwise diagnostic approach can substantially reduce diagnostic delay and facilitate access to disease-specific therapies.

PubMedVol. 186
Università degli Studi di Enna Kore (IT), University of Catania (IT), Ospedale Cannizzaro (IT), Azienda Ospedaliera Universitaria Policlinico "G. Martino" (IT), Azienda Ospedaliero Universitaria Policlinico "G.Rodolico - San Marco" (IT)
Metabolism and Genetic Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon